Clinical trial
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
NCT00544713 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
- Lead sponsor
- Allergan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- June 30, 2008
- Enrollment
- 228 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye syndrome